MoonLake Immunotherapeutics
MLTX
#5899
Rank
A$1.55 B
Marketcap
A$21.90
Share price
-3.45%
Change (1 day)
-73.28%
Change (1 year)

Earnings for MoonLake Immunotherapeutics (MLTX)

Earnings in 2025 (TTM): -A$0.33 Billion

According to MoonLake Immunotherapeutics's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -A$0.2 Billion a decrease over its 2023 earnings that were of -A$81.45 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for MoonLake Immunotherapeutics from 2022 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$0.33 Billion66.18%
2024 -A$0.2 Billion142.55%
2023 -A$81.45 Million-16.81%
2022 -A$97.92 Million